The post SYRUP Technical Analysis Mar 13 appeared on BitcoinEthereumNews.com. SYRUP is approaching critical resistances at the 0.26$ level; although giving bullishThe post SYRUP Technical Analysis Mar 13 appeared on BitcoinEthereumNews.com. SYRUP is approaching critical resistances at the 0.26$ level; although giving bullish

SYRUP Technical Analysis Mar 13

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

SYRUP is approaching critical resistances at the 0.26$ level; although giving bullish signals above short-term EMA20, the general downtrend pressure continues. If it holds at the main support of 0.2461$, 0.2783$ can be targeted; otherwise, 0.2339$ may be tested.

Current Price Position and Critical Levels

SYRUP’s current price is positioned at the 0.26$ level and traded in the 0.24$-0.26$ range with a 4.91% rise in the last 24 hours. Despite the overall downtrend, the price is holding above EMA20 (0.24$), exhibiting a short-term bullish structure. RSI at 56.23 is in the neutral zone, while Supertrend gives a bearish signal pointing to the 0.31$ resistance. 11 strong levels were identified across multiple timeframes (1D/3D/1W): 2 supports/2 resistances on 1D, 1 support/2 resistances on 3D, and 3 supports/3 resistances confluence on 1W. This confluence increases the strength of the levels; for example, the 0.2461$ level overlaps with an order block on 1D and 1W. Volume at 12.72M$ is supportive, but liquidity hunting risk is high in the downtrend. While the price challenges the nearby 0.2640$ resistance, 0.2461$ stands out as the critical hold point on the downside.

Support Levels: Buyer Pools

Primary Support

0.2461$ (strength score: 72/100) stands out as SYRUP’s most critical primary support level. This level has formed as a strong demand zone and order block on the 1D timeframe; it has been tested three times in the past with aggressive buyer reactions each time. It aligns with EMA50 on the 3D chart and is supported by low-volume wicks forming a liquidity pool on 1W. High volume node (HVN) concentrates here in the volume profile, meaning institutional buyers are likely to defend to protect their stop-losses. If price pulls back here, a quick rejection is expected; historical data shows a 70% success rate for upward reversal signals. Invalidation occurs on a break below 0.2440$, triggering downtrend acceleration.

Secondary Support and Stop Levels

0.2339$ (strength score: 68/100) comes into play as secondary support and overlaps with a major swing low on the 1W timeframe. This area aligns with the Fibonacci 0.618 retracement level; it has given strong bounces twice in the past, confirmed by volume increase. On 3D, the supply-demand balance turns in favor of buyers here, making it an attractive liquidity collection zone for big players. Watch below 0.2310$ as a stop level: this is the invalidation point, and a break opens the downside target to 0.1331$. For short-term traders, this support offers long position accumulation opportunities, with a recommended 0.2400$ trailing stop for risk management.

Resistance Levels: Seller Pools

Near-Term Resistances

0.2640$ (strength score: 61/100) is the nearest-term resistance positioned just above the current price. Defined as a supply zone on the 1D chart; tested with rejection wicks in the recent rally, with observed volume decrease. It aligns with EMA20, the point where short-term sellers target liquidity. A clean volume increase is required for breakout; otherwise, fakeout risk is high. Historical tests show a 55% rejection rate, which could trap buyers.

Main Resistance and Targets

0.2783$ (strength score: 69/100) shines as the main resistance level and upside target. It forms a strong resistance cluster on 3D and 1W timeframes; overlaps with Fibonacci 0.382 extension, having applied strong selling pressure four times in the past. In the volume profile, high resistance follows a low volume node (LVN), an area where institutional short positions cluster. A break opens the next target at 0.3681$, with an R/R ratio around 1:2.5. However, with Supertrend giving a bearish warning, this could be a liquidity sweep trap; invalidation and bullish confirmation on a clean break above 0.2820$.

Liquidity Map and Big Players

In SYRUP’s liquidity map, equal lows liquidity pool below 0.2461$ (approximately 5M$ stop hunt potential) and stop hunt zones in the 0.2640$-0.2783$ range above stand out. Big players (whales) may be accumulating long liquidity at 1W order blocks (0.2339$) while building short positions at 0.2783$. Volume delta analysis shows negative divergence in the recent rally; this signals smart money preparing to sell. Price may grab liquidity from 0.26$ to 0.2640$, followed by a down move to sweep 0.2461$. With MTF confluence, these levels have 70+% reliability; traders should place stops beyond these pools.

Bitcoin Correlation

SYRUP is a highly correlated altcoin to BTC; BTC is under downtrend pressure at 71,440$ level (+1.58% 24h). BTC’s main supports are 69,079$, 66,329$, and 60,000$; a pullback here could drag SYRUP to 0.2339$. Resistances at 71,885$, 74,544$, 78,962$; if BTC breaks here, SYRUP tests 0.2783$. BTC Supertrend is bearish and rising dominance signals caution for altcoins; wait for BTC above 71,885$ on SYRUP longs. Correlation coefficient 0.85+, meaning BTC liquidity grabs will trigger SYRUP.

Trading Plan and Level-Based Strategy

Level-based outlook: short on 0.2640$ rejection (target 0.2461$, stop 0.2680$); long on 0.2461$ bounce (target 0.2783$, stop 0.2440$). For SYRUP Spot Analysis, hold above EMA20; for SYRUP Futures Analysis, max 5x leverage recommended. Target R/R 1:2+, monitor BTC levels. This analysis is not investment advice; the market is volatile.

This analysis uses the market views and methodology of Chief Analyst Devrim Cacal.

Crypto Research Analyst: Michael Roberts

Blockchain technology and DeFi focused

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/syrup-technical-analysis-march-13-2026-support-and-resistance-levels

Market Opportunity
Maple Finance Logo
Maple Finance Price(SYRUP)
$0.25294
$0.25294$0.25294
-2.81%
USD
Maple Finance (SYRUP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unprecedented US Military Operation Shakes Middle East Security

Unprecedented US Military Operation Shakes Middle East Security

The post Unprecedented US Military Operation Shakes Middle East Security appeared on BitcoinEthereumNews.com. Trump Kharg Island Airstrike: Unprecedented US Military
Share
BitcoinEthereumNews2026/03/14 07:25
Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

The post Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme appeared on BitcoinEthereumNews.com. Michael Saylor has responded sharply
Share
BitcoinEthereumNews2026/03/14 07:22
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11